US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 3.250
  • +0.280+9.43%
Close Nov 22 16:00 ET
  • 3.250
  • 0.0000.00%
Post 16:02 ET
175.30MMarket Cap-11206P/E (TTM)

Fulcrum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fulcrum Therapeutics Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
-100.00%
-100.00%
--
EPS
-0.40
-0.35
+0.05
Beat Est.
-2.56%
+10.26%
+12.48%
Analyst Rating
Hold

Nov 19, 2024

Fulcrum Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Jul 31, 20242024/Q280.000M / 41.113M--
May 13, 20242024/Q10.000 / 360.140K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Jul 31, 20242024/Q280.000M / 41.113M--
May 13, 20242024/Q10.000 / 360.140K--

Unlock Free Earnings Estimates

Fulcrum Therapeutics Earnings Reports

  • Fulcrum Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 07:13 ET

  • Fulcrum Therapeutics | 10-Q: Q2 2024 Earnings Report

    Jul 31 07:21 ET

  • Fulcrum Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 07:19 ET

  • Fulcrum Therapeutics | 10-K: FY2023 Annual Report

    Feb 27 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 19, 2024

    Hold

    • Buy

      14.29%

    • Hold

      71.43%

    • Sell

      14.29%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data